SOX9 and Myocardin Counteract Each Other in Regulating Vascular Smooth Muscle Cell Differentiation

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2012 May 15

PMID 22580282

Citations 28

Authors

Zhonghui Xu

Guangdong Ji

Jianbin Shen

Xiaobo Wang

Jiliang Zhou

Li Li

Affiliations

Soon will be listed here.

Abstract

Transdifferentiation of vascular smooth muscle cells (VSMC) into chondrogenic cells contributes significantly to vascular calcification during the pathogenesis of atherosclerosis. However, the transcriptional mechanisms that control such phenotypic switch remain unclear. This process is characterized by the induction of Sox9 and Col2a1 genes accompanied by the repression of myocardin (Myocd) and SMC differentiation markers such as SM22, SM α-actin and SM-MHC. Here we explore the regulatory role of SOX9, the master regulator for chondrogenesis, in modulating SMC marker gene expression. qRT-PCR and luciferase assays show that over-expression of SOX9 inhibits SMC gene transcription and promoter activities induced by myocardin, the master regulator of smooth muscle differentiation. Such suppression is independent of the CArG box in the SMC promoters but dependent on myocardin. EMSA assay further shows that SOX9 neither participates in SRF (serum response factor) binding to the CArG box nor interacts with SRF, while co-immunoprecipitation demonstrates an association of SOX9 with myocardin. Conversely, myocardin suppresses SOX9-mediated chondrogenic gene Col2a1 expression. These findings provide the first mechanistic insights into the important regulatory role of SOX9 and myocardin in controlling the transcription program during SMC transdifferentiation into chondrocytes.

Citing Articles

SM22α deficiency: promoting vascular fibrosis via SRF-SMAD3-mediated activation of transcription following arterial injury.

Shen J, Ju D, Wu S, Zhao J, Pham L, Ponce A Res Sq. 2024; .

PMID: 38464061 PMC: 10925461. DOI: 10.21203/rs.3.rs-3941602/v1.

Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.

Faleeva M, Ahmad S, Theofilatos K, Lynham S, Watson G, Whitehead M Circ Res. 2024; 134(3):307-324.

PMID: 38179698 PMC: 10826924. DOI: 10.1161/CIRCRESAHA.123.323365.

Microvascular smooth muscle cells exhibit divergent phenotypic switching responses to platelet-derived growth factor and insulin-like growth factor 1.

Bickel M, Sherry D, Bullen E, Vance M, Jones K, Howard E Microvasc Res. 2023; 151():104609.

PMID: 37716411 PMC: 10842624. DOI: 10.1016/j.mvr.2023.104609.

Vascular smooth muscle-specific YAP/TAZ deletion triggers aneurysm development in mouse aorta.

Martinez M, Ritsvall O, Bastrup J, Celik S, Jakobsson G, Daoud F JCI Insight. 2023; 8(17).

PMID: 37561588 PMC: 10544211. DOI: 10.1172/jci.insight.170845.

Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.

Ma J, Li Y, Yang X, Liu K, Zhang X, Zuo X Signal Transduct Target Ther. 2023; 8(1):168.

PMID: 37080965 PMC: 10119183. DOI: 10.1038/s41392-023-01430-7.

References

Davies J, Carpenter K, Challis I, Figg N, McNair R, Proudfoot D . Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem. 2004; 280(5):3911-9. DOI: 10.1074/jbc.M410075200. View

Otto F, Thornell A, Crompton T, Denzel A, Gilmour K, Rosewell I . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89(5):765-71. DOI: 10.1016/s0092-8674(00)80259-7. View

Bobryshev Y . Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol. 2005; 205(5):641-50. DOI: 10.1002/path.1743. View

Owens G, Kumar M, Wamhoff B . Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84(3):767-801. DOI: 10.1152/physrev.00041.2003. View

Peng H, Tan L, Osaki M, Zhan Y, Ijiri K, Tsuchimochi K . ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol. 2007; 215(2):562-73. PMC: 3937869. DOI: 10.1002/jcp.21338. View

Speer M, Yang H, Brabb T, Leaf E, Look A, Lin W . Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009; 104(6):733-41. PMC: 2716055. DOI: 10.1161/CIRCRESAHA.108.183053. View

Liu Y, Sinha S, McDonald O, Shang Y, Hoofnagle M, Owens G . Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem. 2004; 280(10):9719-27. DOI: 10.1074/jbc.M412862200. View

Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Bostrom K . Multilineage potential of cells from the artery wall. Circulation. 2003; 108(20):2505-10. DOI: 10.1161/01.CIR.0000096485.64373.C5. View

Zhou J, Hu G, Wang X . Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1. J Biol Chem. 2010; 285(30):23177-85. PMC: 2906311. DOI: 10.1074/jbc.M110.109868. View

10.

Carson J, Fillmore R, Schwartz R, Zimmer W . The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor. J Biol Chem. 2000; 275(50):39061-72. DOI: 10.1074/jbc.M006532200. View

11.

Tanaka T, Sato H, Doi H, Yoshida C, Shimizu T, Matsui H . Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol. 2007; 28(3):1147-60. PMC: 2223399. DOI: 10.1128/MCB.01771-07. View

12.

Dandre F, Owens G . Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol. 2004; 286(6):H2042-51. DOI: 10.1152/ajpheart.00625.2003. View

13.

Wang D, Chang P, Wang Z, Sutherland L, Richardson J, Small E . Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105(7):851-62. DOI: 10.1016/s0092-8674(01)00404-4. View

14.

Ahdjoudj S, Lasmoles F, Oyajobi B, Lomri A, Delannoy P, Marie P . Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem. 2001; 81(1):23-38. DOI: 10.1002/1097-4644(20010401)81:1<23::aid-jcb1021>3.0.co;2-h. View

15.

Tyson K, Reynolds J, McNair R, Zhang Q, Weissberg P, Shanahan C . Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol. 2003; 23(3):489-94. DOI: 10.1161/01.ATV.0000059406.92165.31. View

16.

Neven E, Persy V, Dauwe S, De Schutter T, De Broe M, DHaese P . Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol. 2010; 30(9):1741-50. DOI: 10.1161/ATVBAHA.110.204834. View

17.

Akiyama H, Chaboissier M, Martin J, Schedl A, de Crombrugghe B . The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002; 16(21):2813-28. PMC: 187468. DOI: 10.1101/gad.1017802. View

18.

Sundberg-Smith L, DiMichele L, Sayers R, Mack C, Taylor J . The LIM protein leupaxin is enriched in smooth muscle and functions as an serum response factor cofactor to induce smooth muscle cell gene transcription. Circ Res. 2008; 102(12):1502-11. PMC: 2785029. DOI: 10.1161/CIRCRESAHA.107.170357. View

19.

Chen J, Kitchen C, Streb J, Miano J . Myocardin: a component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol. 2002; 34(10):1345-56. DOI: 10.1006/jmcc.2002.2086. View

20.

Li L, Liu Z, Mercer B, Overbeek P, Olson E . Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol. 1997; 187(2):311-21. DOI: 10.1006/dbio.1997.8621. View